NCT00357240 - Drug Interaction Study With Proton Pump Inhibitor | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

HIV Infections

Interventions

DRUG

Atazanavir

Capsules, Oral, 400 mg, once daily, 6 days.

DRUG

Atazanavir/Ritonavir

Capsules/capsules, Oral, 300/100 mg, once daily, 10 days.

DRUG

Atazanavir/Ritonavir+Omeprazole

Capsules/capsules + Capsules, Oral, 300/100 mg + 20 mg, once daily in PM + once daily in AM, 7 days.

DRUG

Atazanavir/Ritonavir+Omeprazole

Capsules/capsules + Capsules, Oral, 400/100 mg + 20 mg, once daily in PM + once daily in AM, 7 days.

DRUG

Atazanavir

Capsules, Oral, 400 mg, once daily, 6 days.

DRUG

Atazanavir/Ritonavir

Capsules/capsules, Oral, 300/100 mg, once daily, 10 days.

DRUG

Atazanavir/Ritonavir+Omeprazole

Capsules/capsules + Capsules, Oral, 400/100 mg + 20 mg, once daily in AM + once daily in AM, 7 days.

DRUG

Atazanavir/Ritonavir+Omeprazole

Capsules/capsules + Capsules, Oral, 400/100 mg + 20 mg, once daily in AM + once daily in PM, 7 days.

Trial Locations (1)

Local Institution, Hamilton